Working… Menu
Trial record 1 of 3 for:    "Pituitary Adenoma 4, Acth-Secreting" | "Neurotransmitter Agents"
Previous Study | Return to List | Next Study

Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01915303
Recruitment Status : Active, not recruiting
First Posted : August 2, 2013
Last Update Posted : June 17, 2019
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : September 5, 2016
Estimated Study Completion Date : December 31, 2019